Premium innovation drives Unilever’s positive aspects in Magnificence & Wellbeing

Key takeaways on Unilever 2025 outcomes

• Unilever reported stable 2025 progress in Magnificence & Wellbeing (4.3%) and Private Care (4.7%).
• Premium innovation and science‑led product launches fuelled efficiency throughout Dove, Vaseline, Hourglass and K18.
• Wellbeing manufacturers together with Nutrafol, Liquid I.V. and OLLY delivered double‑digit progress.
• Robust Asia Pacific Africa efficiency supported fourth‑quarter momentum.
• Working margins mirrored elevated model funding behind Energy Manufacturers and premium classes.

In 2025, Unilever’s strategic reshape accelerated, because the enterprise put extra concentrate on its Magnificence & Wellbeing and Private Care classes.

“We’re transferring at pace to construct a enterprise that drives want at scale in our manufacturers, execution excellence throughout all channels and value self-discipline,” defined CEO, Fernando Fernandez. “We’ve set clear priorities for progress – constructing a model portfolio for the longer term, with extra Magnificence, Wellbeing and Private Care, prioritising premium segments and digital commerce, and anchoring our progress within the US and India.”

Vaseline and Dove increase magnificence progress

The Magnificence & Wellbeing division, representing 25% of group turnover, reported underlying gross sales progress of 4.3%, with 2.2% from quantity and a couple of.1% from value.

Progress was pushed by double‑digit will increase in Wellbeing, Vaseline and Dove, which have all targeted on science‑led, premium improvements.

Fourth‑quarter progress reached 4.7% (with 2.8% from quantity), supported by improved efficiency throughout a number of key markets in Asia Pacific and Africa.

Wellbeing continued to outperform its class, though progress had slowed down.

Hair Care grew at a low single‑digit charge, with optimistic pricing partially offset by detrimental quantity. Dove haircare grew double‑digit with balanced quantity and value, pushed by the launch of its new fibre‑restore expertise vary. This was partially offset by portfolio rationalisation and weaker efficiency in some rising markets, affecting manufacturers reminiscent of Sunsilk and Clear.

Core Pores and skin Care delivered mid‑single‑digit progress, with optimistic contributions from each quantity and value. Vaseline led the efficiency with double‑digit progress for the third consecutive 12 months.

Wellbeing delivered double‑digit progress, pushed primarily by quantity. Nutrafol and Liquid I.V. posted double‑digit progress, whereas OLLY grew at a excessive single‑digit charge, supported by premium gummy improvements.

Status Magnificence grew at a low‑single‑digit charge, led by pricing. Progress was pushed by sturdy double‑digit efficiency in Hourglass and K18. Dermalogica and Paula’s Alternative declined however returned to progress within the second half.

Underlying working revenue for the division was €2.5bn, down 3.2% 12 months‑on‑12 months.

Private Care efficiency strengthens regardless of combined market situations

In the meantime, Private Care, which represents 26% of group turnover, delivered underlying gross sales progress of 4.7%, with 1.1% from quantity and three.6% from value.

Progress was led by commodity‑pushed value will increase, whereas quantity was supported by premium innovation – significantly in Dove, which grew at a excessive single‑digit charge.

Robust quantity progress in developed markets was partially offset by a decline in Latin America, nevertheless the enterprise nonetheless outperformed the market.

Fourth‑quarter progress remained sturdy at 5.1%, with optimistic quantity and accelerating value progress.

Deodorants grew at a low single‑digit charge, with optimistic contributions from each value and quantity. The expansion was led by double‑digit growth in Dove, supported by the continued success of Entire Physique Deodorants. This was partly offset by quantity declines in Latin America.

This fall progress improved to mid‑single‑digit ranges, supported by early progress on actions taken to enhance format combine in Brazil.

Pores and skin Cleaning grew at a mid‑single‑digit charge, pushed by pricing and premiumisation. Dove grew mid‑single digit, whereas Lifebuoy was flat attributable to volumes being impacted by commodity‑pushed value will increase.

Oral Care grew mid‑single digit, pushed by sturdy efficiency in Closeup and Pepsodent as each manufacturers launched premium improvements, together with whitening and naturals ranges.

Underlying working revenue for Private Care was €3bn, down 1.4% on the prior 12 months.

gross sales for 2026, Fernandez mentioned that regardless of slowing markets the world over, he nonetheless had loads of confidence for the 12 months forward.